Global and United States Opioids Market Insights, Forecast to 2027

Publisher Name :
Date: 20-Aug-2021
No. of pages: 142
Inquire Before Buying

Opioids market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Opioids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Opioids market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Oxycodone

- Hydromorphone

- Codeine

- Fentanyl

- Other

Segment by Application

- Pain Relief

- Anesthesia

- Cough Suppression

- Diarrhea Suppression

- Deaddiction

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Teva

- Purdue Pharma

- Mallinckrodt

- Amneal Pharma

- Collegium

- J&J

- Endo

- Pfizer

- INSYS

- Mylan

- Hikma

- Egalet

Global and United States Opioids Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Opioids Product Introduction
1.2 Market by Type
1.2.1 Global Opioids Market Size Growth Rate by Type
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Market by Application
1.3.1 Global Opioids Market Size Growth Rate by Application
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Opioids Market Size, Estimates and Forecasts
2.1.1 Global Opioids Revenue 2016-2027
2.1.2 Global Opioids Sales 2016-2027
2.2 Global Opioids, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Opioids Historical Market Size by Region (2016-2021)
2.3.1 Global Opioids Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Opioids Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Opioids Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Opioids Sales Forecast by Region (2022-2027)
2.4.2 Global Opioids Revenue Forecast by Region (2022-2027)
3 Global Opioids Competitor Landscape by Players
3.1 Global Top Opioids Manufacturers by Sales
3.1.1 Global Opioids Sales by Manufacturer (2016-2021)
3.1.2 Global Opioids Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Opioids Manufacturers by Revenue
3.2.1 Key Opioids Manufacturers Covered: Ranking by Revenue
3.2.2 Global Opioids Revenue by Manufacturers (2016-2021)
3.2.3 Global Opioids Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Opioids Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Opioids Revenue in 2020
3.2.6 Global Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Opioids Price by Manufacturers
3.4 Global Opioids Manufacturing Base Distribution, Product Types
3.4.1 Opioids Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioids Product Type
3.4.3 Date of International Manufacturers Enter into Opioids Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Opioids Market Size by Type (2016-2021)
4.1.1 Global Opioids Sales by Type (2016-2021)
4.1.2 Global Opioids Revenue by Type (2016-2021)
4.1.3 Opioids Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Opioids Market Size Forecast by Type (2022-2027)
4.2.1 Global Opioids Sales Forecast by Type (2022-2027)
4.2.2 Global Opioids Revenue Forecast by Type (2022-2027)
4.2.3 Opioids Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Opioids Market Size by Application (2016-2021)
5.1.1 Global Opioids Sales by Application (2016-2021)
5.1.2 Global Opioids Revenue by Application (2016-2021)
5.1.3 Opioids Price by Application (2016-2021)
5.2 Opioids Market Size Forecast by Application (2022-2027)
5.2.1 Global Opioids Sales Forecast by Application (2022-2027)
5.2.2 Global Opioids Revenue Forecast by Application (2022-2027)
5.2.3 Global Opioids Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Opioids Market Size YoY Growth 2016-2027
6.1.1 United States Opioids Sales YoY Growth 2016-2027
6.1.2 United States Opioids Revenue YoY Growth 2016-2027
6.1.3 United States Opioids Market Share in Global Market 2016-2027
6.2 United States Opioids Market Size by Players (International and Local Players)
6.2.1 United States Top Opioids Players by Sales (2016-2021)
6.2.2 United States Top Opioids Players by Revenue (2016-2021)
6.3 United States Opioids Historic Market Review by Type (2016-2021)
6.3.1 United States Opioids Sales Market Share by Type (2016-2021)
6.3.2 United States Opioids Revenue Market Share by Type (2016-2021)
6.3.3 United States Opioids Price by Type (2016-2021)
6.4 United States Opioids Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Opioids Sales Forecast by Type (2022-2027)
6.4.2 United States Opioids Revenue Forecast by Type (2022-2027)
6.4.3 United States Opioids Price Forecast by Type (2022-2027)
6.5 United States Opioids Historic Market Review by Application (2016-2021)
6.5.1 United States Opioids Sales Market Share by Application (2016-2021)
6.5.2 United States Opioids Revenue Market Share by Application (2016-2021)
6.5.3 United States Opioids Price by Application (2016-2021)
6.6 United States Opioids Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Opioids Sales Forecast by Application (2022-2027)
6.6.2 United States Opioids Revenue Forecast by Application (2022-2027)
6.6.3 United States Opioids Price Forecast by Application (2022-2027)
7 North America
7.1 North America Opioids Market Size YoY Growth 2016-2027
7.2 North America Opioids Market Facts & Figures by Country
7.2.1 North America Opioids Sales by Country (2016-2021)
7.2.2 North America Opioids Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Opioids Market Size YoY Growth 2016-2027
8.2 Asia Pacific Opioids Market Facts & Figures by Region
8.2.1 Asia Pacific Opioids Sales by Region (2016-2021)
8.2.2 Asia Pacific Opioids Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Opioids Market Size YoY Growth 2016-2027
9.2 Europe Opioids Market Facts & Figures by Country
9.2.1 Europe Opioids Sales by Country (2016-2021)
9.2.2 Europe Opioids Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Opioids Market Size YoY Growth 2016-2027
10.2 Latin America Opioids Market Facts & Figures by Country
10.2.1 Latin America Opioids Sales by Country (2016-2021)
10.2.2 Latin America Opioids Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Opioids Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Opioids Market Facts & Figures by Country
11.2.1 Middle East and Africa Opioids Sales by Country (2016-2021)
11.2.2 Middle East and Africa Opioids Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Description and Business Overview
12.1.3 Teva Opioids Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Opioids Products Offered
12.1.5 Teva Recent Development
12.2 Purdue Pharma
12.2.1 Purdue Pharma Corporation Information
12.2.2 Purdue Pharma Description and Business Overview
12.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Purdue Pharma Opioids Products Offered
12.2.5 Purdue Pharma Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Description and Business Overview
12.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Opioids Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Amneal Pharma
12.4.1 Amneal Pharma Corporation Information
12.4.2 Amneal Pharma Description and Business Overview
12.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Amneal Pharma Opioids Products Offered
12.4.5 Amneal Pharma Recent Development
12.5 Collegium
12.5.1 Collegium Corporation Information
12.5.2 Collegium Description and Business Overview
12.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Collegium Opioids Products Offered
12.5.5 Collegium Recent Development
12.6 J&J
12.6.1 J&J Corporation Information
12.6.2 J&J Description and Business Overview
12.6.3 J&J Opioids Sales, Revenue and Gross Margin (2016-2021)
12.6.4 J&J Opioids Products Offered
12.6.5 J&J Recent Development
12.7 Endo
12.7.1 Endo Corporation Information
12.7.2 Endo Description and Business Overview
12.7.3 Endo Opioids Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Endo Opioids Products Offered
12.7.5 Endo Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Opioids Products Offered
12.8.5 Pfizer Recent Development
12.9 INSYS
12.9.1 INSYS Corporation Information
12.9.2 INSYS Description and Business Overview
12.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2016-2021)
12.9.4 INSYS Opioids Products Offered
12.9.5 INSYS Recent Development
12.10 Mylan
12.10.1 Mylan Corporation Information
12.10.2 Mylan Description and Business Overview
12.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Mylan Opioids Products Offered
12.10.5 Mylan Recent Development
12.11 Teva
12.11.1 Teva Corporation Information
12.11.2 Teva Description and Business Overview
12.11.3 Teva Opioids Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teva Opioids Products Offered
12.11.5 Teva Recent Development
12.12 Egalet
12.12.1 Egalet Corporation Information
12.12.2 Egalet Description and Business Overview
12.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Egalet Products Offered
12.12.5 Egalet Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Opioids Industry Trends
13.2 Opioids Market Drivers
13.3 Opioids Market Challenges
13.4 Opioids Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioids Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Opioids Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oxycodone
Table 3. Major Manufacturers of Hydromorphone
Table 4. Major Manufacturers of Codeine
Table 5. Major Manufacturers of Fentanyl
Table 6. Major Manufacturers of Other
Table 7. Global Opioids Market Size Growth Rate by Application (2021-2027) & (MT)
Table 8. Global Opioids Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Opioids Sales by Regions (2016-2021) & (MT)
Table 10. Global Opioids Sales Market Share by Regions (2016-2021)
Table 11. Global Opioids Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Opioids Sales Forecast by Region (2022-2027) & (MT)
Table 13. Global Opioids Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Opioids Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Opioids Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Opioids Sales by Manufacturers (2016-2021) (MT)
Table 17. Global Opioids Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Opioids Manufacturers by Revenue (US$ Million) in 2020
Table 19. Opioids Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Opioids Revenue Share by Manufacturers (2016-2021)
Table 21. Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Opioids by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids as of 2020)
Table 23. Key Manufacturers Opioids Price (2016-2021) (USD/Kg)
Table 24. Opioids Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Opioids Product Type
Table 26. Date of International Manufacturers Enter into Opioids Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Opioids Sales by Type (2016-2021) (MT)
Table 29. Global Opioids Sales Share by Type (2016-2021)
Table 30. Global Opioids Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Opioids Revenue Share by Type (2016-2021)
Table 32. Opioids Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 33. Global Opioids Sales Forecast by Type (2022-2027) & (MT)
Table 34. Global Opioids Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Opioids Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Opioids Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Opioids Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 38. Global Opioids Sales by Application (2016-2021) (MT)
Table 39. Global Opioids Sales Share by Application (2016-2021)
Table 40. Global Opioids Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Opioids Revenue Share by Application (2016-2021)
Table 42. Opioids Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 43. Global Opioids Sales Forecast by Application (2022-2027) & (MT)
Table 44. Global Opioids Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Opioids Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Opioids Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Opioids Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 48. United States Opioids Sales (MT) of Key Companies (2016-2021)
Table 49. United States Opioids Sales Share by Company (2016-2021)
Table 50. United States Opioids Revenue (US$ Million) by Company (2016-2021)
Table 51. United States Opioids Revenue Share by Company (2016-2021)
Table 52. United States Opioids Sales (MT) by Type (2016-2021)
Table 53. United States Opioids Sales Share by Type (2016-2021)
Table 54. United States Opioids Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. United States Opioids Price (USD/Kg) by Type (2016-2021)
Table 56. United States Opioids Sales (MT) by Type (2022-2027)
Table 57. United States Opioids Sales Share by Type (2022-2027)
Table 58. United States Opioids Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. United States Opioids Revenue Share by Type (2022-2027)
Table 60. United States Opioids Price (USD/Kg) by Type (2022-2027)
Table 61. United States Opioids Sales (MT) by Application (2016-2021)
Table 62. United States Opioids Sales Share by Application (2016-2021)
Table 63. United States Opioids Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. United States Opioids Price (USD/Kg) by Application (2016-2021)
Table 65. United States Opioids Sales (MT) by Application (2022-2027)
Table 66. United States Opioids Sales Share by Application (2022-2027)
Table 67. United States Opioids Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. United States Opioids Revenue Share by Application (2022-2027)
Table 69. United States Opioids Price (USD/Kg) by Application (2022-2027)
Table 70. North America Opioids Sales by Country (2016-2021) & (MT)
Table 71. North America Opioids Sales Market Share by Country (2016-2021)
Table 72. North America Opioids Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Opioids Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Opioids Sales by Region (2016-2021) & (MT)
Table 75. Asia Pacific Opioids Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Opioids Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Opioids Revenue Market Share by Region (2016-2021)
Table 78. Europe Opioids Sales by Country (2016-2021) & (MT)
Table 79. Europe Opioids Sales Market Share by Country (2016-2021)
Table 80. Europe Opioids Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Opioids Revenue Market Share by Country (2016-2021)
Table 82. Latin America Opioids Sales by Country (2016-2021) & (MT)
Table 83. Latin America Opioids Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Opioids Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Opioids Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Opioids Sales by Country (2016-2021) & (MT)
Table 87. Middle East and Africa Opioids Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Opioids Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Opioids Revenue Market Share by Country (2016-2021)
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 93. Teva Opioids Product
Table 94. Teva Recent Development
Table 95. Purdue Pharma Corporation Information
Table 96. Purdue Pharma Description and Business Overview
Table 97. Purdue Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 98. Purdue Pharma Product
Table 99. Purdue Pharma Recent Development
Table 100. Mallinckrodt Corporation Information
Table 101. Mallinckrodt Description and Business Overview
Table 102. Mallinckrodt Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 103. Mallinckrodt Product
Table 104. Mallinckrodt Recent Development
Table 105. Amneal Pharma Corporation Information
Table 106. Amneal Pharma Description and Business Overview
Table 107. Amneal Pharma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 108. Amneal Pharma Product
Table 109. Amneal Pharma Recent Development
Table 110. Collegium Corporation Information
Table 111. Collegium Description and Business Overview
Table 112. Collegium Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Collegium Product
Table 114. Collegium Recent Development
Table 115. J&J Corporation Information
Table 116. J&J Description and Business Overview
Table 117. J&J Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. J&J Product
Table 119. J&J Recent Development
Table 120. Endo Corporation Information
Table 121. Endo Description and Business Overview
Table 122. Endo Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Endo Product
Table 124. Endo Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Pfizer Product
Table 129. Pfizer Recent Development
Table 130. INSYS Corporation Information
Table 131. INSYS Description and Business Overview
Table 132. INSYS Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. INSYS Product
Table 134. INSYS Recent Development
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Business Overview
Table 137. Mylan Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Mylan Product
Table 139. Mylan Recent Development
Table 140. Hikma Corporation Information
Table 141. Hikma Description and Business Overview
Table 142. Hikma Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Hikma Product
Table 144. Hikma Recent Development
Table 145. Egalet Corporation Information
Table 146. Egalet Description and Business Overview
Table 147. Egalet Opioids Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 148. Egalet Product
Table 149. Egalet Recent Development
Table 150. Opioids Market Trends
Table 151. Opioids Market Drivers
Table 152. Opioids Market Challenges
Table 153. Opioids Market Restraints
Table 154. Opioids Customers List
Table 155. Opioids Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Product Picture
Figure 2. Global Opioids Sales Market Share by Type in 2020 & 2027
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Other Product Picture
Figure 8. Global Opioids Sales Market Share by Application in 2020 & 2027
Figure 9. Pain Relief
Figure 10. Anesthesia
Figure 11. Cough Suppression
Figure 12. Diarrhea Suppression
Figure 13. Deaddiction
Figure 14. Others
Figure 15. Opioids Report Years Considered
Figure 16. Global Opioids Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Opioids Market Size 2016-2027 (US$ Million)
Figure 18. Global Opioids Sales 2016-2027 (MT)
Figure 19. Global Opioids Market Size Market Share by Region: 2021 Versus 2027
Figure 20. Global Opioids Sales Market Share by Region (2016-2021)
Figure 21. Global Opioids Sales Market Share by Region in 2020
Figure 22. Global Opioids Revenue Market Share by Region (2016-2021)
Figure 23. Global Opioids Revenue Market Share by Region in 2020
Figure 24. Global Opioids Sales Share by Manufacturer in 2020
Figure 25. The Top 10 and 5 Players Market Share by Opioids Revenue in 2020
Figure 26. Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 27. Global Opioids Sales Market Share by Type (2016-2021)
Figure 28. Global Opioids Sales Market Share by Type in 2020
Figure 29. Global Opioids Revenue Market Share by Type (2016-2021)
Figure 30. Global Opioids Revenue Market Share by Type in 2020
Figure 31. Global Opioids Sales Market Share by Application (2016-2021)
Figure 32. Global Opioids Sales Market Share by Application in 2020
Figure 33. Global Opioids Revenue Market Share by Application (2016-2021)
Figure 34. Global Opioids Revenue Market Share by Application in 2020
Figure 35. United States Opioids Sales Growth Rate 2016-2027 (MT)
Figure 36. United States Opioids Revenue Growth Rate 2016-2027 (US$ Million)
Figure 37. United States Opioids Market Share in Global Market 2016-2027
Figure 38. United States 5 and 10 Largest Opioids Players Market Share by Revenue in Opioids in 2020
Figure 39. United States Opioids Revenue Share by Type (2016-2021)
Figure 40. United States Opioids Revenue Growth Rate by Type in 2016 & 2020
Figure 41. United States Opioids Revenue Share by Application (2016-2021)
Figure 42. United States Opioids Revenue Growth Rate by Application in 2016 & 2020
Figure 43. North America Opioids Sales Growth Rate 2016-2021 (MT)
Figure 44. North America Opioids Revenue Growth Rate 2016-2021 (US$ Million)
Figure 45. North America Opioids Sales Market Share by Country in 2020
Figure 46. North America Opioids Revenue Market Share by Country in 2020
Figure 47. U.S. Opioids Sales Growth Rate (2016-2021) (MT)
Figure 48. U.S. Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Canada Opioids Sales Growth Rate (2016-2021) (MT)
Figure 50. Canada Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Europe Opioids Sales Growth Rate 2016-2021 (MT)
Figure 52. Europe Opioids Revenue Growth Rate 2016-2021 (US$ Million)
Figure 53. Europe Opioids Sales Market Share by Country in 2020
Figure 54. Europe Opioids Revenue Market Share by Country in 2020
Figure 55. Germany Opioids Sales Growth Rate (2016-2021) (MT)
Figure 56. Germany Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. France Opioids Sales Growth Rate (2016-2021) (MT)
Figure 58. France Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. U.K. Opioids Sales Growth Rate (2016-2021) (MT)
Figure 60. U.K. Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Italy Opioids Sales Growth Rate (2016-2021) (MT)
Figure 62. Italy Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Russia Opioids Sales Growth Rate (2016-2021) (MT)
Figure 64. Russia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Asia Pacific Opioids Sales Growth Rate 2016-2021 (MT)
Figure 66. Asia Pacific Opioids Revenue Growth Rate 2016-2021 (US$ Million)
Figure 67. Asia Pacific Opioids Sales Market Share by Region in 2020
Figure 68. Asia Pacific Opioids Revenue Market Share by Region in 2020
Figure 69. China Opioids Sales Growth Rate (2016-2021) (MT)
Figure 70. China Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Japan Opioids Sales Growth Rate (2016-2021) (MT)
Figure 72. Japan Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. South Korea Opioids Sales Growth Rate (2016-2021) (MT)
Figure 74. South Korea Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. India Opioids Sales Growth Rate (2016-2021) (MT)
Figure 76. India Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Australia Opioids Sales Growth Rate (2016-2021) (MT)
Figure 78. Australia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Taiwan Opioids Sales Growth Rate (2016-2021) (MT)
Figure 80. Taiwan Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Indonesia Opioids Sales Growth Rate (2016-2021) (MT)
Figure 82. Indonesia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Thailand Opioids Sales Growth Rate (2016-2021) (MT)
Figure 84. Thailand Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Malaysia Opioids Sales Growth Rate (2016-2021) (MT)
Figure 86. Malaysia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Philippines Opioids Sales Growth Rate (2016-2021) (MT)
Figure 88. Philippines Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Vietnam Opioids Sales Growth Rate (2016-2021) (MT)
Figure 90. Vietnam Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Latin America Opioids Sales Growth Rate 2016-2021 (MT)
Figure 92. Latin America Opioids Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Latin America Opioids Sales Market Share by Country in 2020
Figure 94. Latin America Opioids Revenue Market Share by Country in 2020
Figure 95. Mexico Opioids Sales Growth Rate (2016-2021) (MT)
Figure 96. Mexico Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Brazil Opioids Sales Growth Rate (2016-2021) (MT)
Figure 98. Brazil Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Argentina Opioids Sales Growth Rate (2016-2021) (MT)
Figure 100. Argentina Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Middle East and Africa Opioids Sales Growth Rate 2016-2021 (MT)
Figure 102. Middle East and Africa Opioids Revenue Growth Rate 2016-2021 (US$ Million)
Figure 103. Middle East and Africa Opioids Sales Market Share by Country in 2020
Figure 104. Middle East and Africa Opioids Revenue Market Share by Country in 2020
Figure 105. Turkey Opioids Sales Growth Rate (2016-2021) (MT)
Figure 106. Turkey Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Saudi Arabia Opioids Sales Growth Rate (2016-2021) (MT)
Figure 108. Saudi Arabia Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. U.A.E Opioids Sales Growth Rate (2016-2021) (MT)
Figure 110. U.A.E Opioids Revenue Growth Rate (2016-2021) (US$ Million)
Figure 111. Opioids Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs